|Articles|July 7, 2004

Miravant PDT laser receives expedited review status

The FDA accepted for filing and granted Expedited Review status to Miravant Medical Technologies' premarket application (PMA) for the IRIS Medical OcuLight 664 ophthalmic PDT laser.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME